Related Experiment Video
Updated: May 10, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
The prevalence of hepatitis C virus in mashhad, iran: a population-based study
Mohammad Taghi Shakeri1, Hosein Nomani, Majid Ghayour Mobarhan
1Department of Biostatistics, Public Health School, Mashhad University of Medical Sciences, Mashhad, IR Iran.
Insights
Hepatitis C virus (HCV) infection prevalence is less than 1% in Mashhad, Iran. This study assessed HCV seropositivity in the general population using ELISA and RT-PCR methods.
Area of Science:
- Epidemiology
- Virology
- Public Health
Background:
- Hepatitis C virus (HCV) infection poses a global health challenge, with chronic infections leading to severe liver disease, cirrhosis, and hepatocellular carcinoma.
- The absence of an HCV vaccine necessitates effective control measures, highlighting the importance of epidemiological studies for disease management.
- Understanding HCV's spread is crucial for community-level interventions and monitoring infection rates.
Purpose of the Study:
- To determine the prevalence of hepatitis C seropositivity in the general population of Mashhad, located in northeast Iran.
- To provide essential data for public health strategies aimed at controlling HCV transmission in the region.
Main Methods:
- A cluster sampling method was employed to recruit 3870 individuals from the general population of Mashhad.
- Hepatitis C virus (HCV) seropositivity was initially assessed using an HCV antibody detection ELISA kit.
- Results from ELISA were confirmed using the more sensitive reverse transcriptase polymerase chain reaction (RT-PCR) method to accurately determine HCV infection prevalence.
Main Results:
- The overall seroprevalence of hepatitis C, detected by ELISA, was found to be 0.2%.
- Confirmation using RT-PCR revealed a lower overall prevalence of Hepatitis C virus infection at 0.13%.
- Both methods indicated a low prevalence rate of HCV in the studied population.
Conclusions:
- The prevalence rate of Hepatitis C virus infection in the general population of Mashhad is below 1%.
- These findings are critical for informing public health policies and interventions in the region.
- Continued surveillance is recommended to monitor and manage HCV infection effectively.
Background:
Hepatitis C virus (HCV) infection is a significant health problem throughout the world. Chronic form of the disease is found in about 75% to 85% of the newly infected individuals. The chronic infection may lead to severe forms including chronic liver disease, cirrhosis and with a higher mortality rate, hepatocellular carcinoma. Since no vaccine has yet been developed against HCV, there is an increasing need to take measures to control the spread of the infection. Therefore, epidemiologic study of the virus is important to manage and monitor the spread of the virus in the community.
Objectives:
The aim of this study was to determine the prevalence of hepatitis C seropositivity in the general population of Mashhad, northeast of Iran.
Patients And Methods:
Three thousand, eight hundred and seventy (3870) individuals living in the city of Mashhad were recruited using cluster sampling method. HCV seropositivity was determined with HCV antibody detection ELISA kit and was confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) method.
Results:
In this study the overall seroprevalence of hepatitis C was founded to be 0.2% by using ELISA method. However, the overall Hepatitis C virus infection prevalence was found to be 0.13% with RT-PCR method.
Conclusions:
Our study suggested that the prevalence rate of Hepatitis C virus is below 1% in the general population of Mashhad.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...